Imprimis Pharmaceuticals Inc IMMY:NASDAQ (Common Stock)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
7.49 -0.23   -2.98% 7,51416.5K
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 10/8/2014

Latest News Headlines for Imprimis Pharmaceuticals Inc

No News for Imprimis Pharmaceuticals Inc

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company's Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company's lead pain product, utilizes the Transdel platform technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its anti-inflammatory and analgesic effects. Ketotransdel consists of a transdermal formulation of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its Transdel drug delivery system and is being developed for the treatment of acute pain. In April 2014, Imprimis Pharmaceuticals Inc acquired Pharmacy Creations LLC, a Randolph-based owner and operator of pharmacies.

http://www.imprimispharma.com/

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open7.73
Previous Close7.49
Day High--
Day Low--
52 Week High3/3/2014 | 9.62
52 Week Low12/13/2013 | 3.01
% Off 52 Week High-22.14%
% Off 52 Week Low148.84%
Beta (5 Yr)-1.30
Volatility Avg10/8/2014 | 61.65
10-Day Avg. Volume16,503
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)6/30/2014 | -0.98
P/E Ratio6/30/2014 | --
Market CapMicro Cap | 68M
Shares Outstanding9.13M
Float4.7M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield--
Ex-Date--
Dividend Announcement--
Date of Record--
Payable-- - --
Payable Date--

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short32.16K
Short Ratio1.9
Short % of Float0.68%
As of 9/15/2014

Peers Information HelpIMMY Imprimis Pharmaceuticals Inc vs. Peers

Peers 
IMMY
Imprimis Pharmaceuticals Inc
122.92%
Eli Lilly and Co
27.92%
Merck & Co., Inc.
20.24%
IMMY
Imprimis Pharmaceuticals Inc
0.00%
Eli Lilly and Co
3.00%
Merck & Co., Inc.
2.92%
IMMY
Imprimis Pharmaceuticals Inc
-2.98%
Eli Lilly and Co
1.59%
Merck & Co., Inc.
2.94%
Compare these stocks